by: Scott Gunther | May 2, 2023 Anyone involved in middle/lower-mid-market private equity has likely noticed the increase in sponsors pursuing buy-and-build (B&B) strategies to consolidate fragmented markets. According to Bain & Co. add-on acquisitions made up 72% of all PE buyout transactions in North America in 2022. B&B platforms have become a popular entry point for many investors

by: Chuck Egoville | April 19, 2023 It is no exaggeration to say that the last few years in private equity have been eventful. According to Bloomberg, private equity M&A activity in 2022 dropped by nearly 40% year-over-year, down more than $800 billion from 2021. That sounds bad, but those numbers only tell part of the story. The

by: Jamey Cummings & Paul Deegan | April 4, 2023 Given the realities of today’s world, people and businesses are finally starting to take their data privacy seriously. Consumers now expect businesses to be attentive and trusted caretakers of their private information. In fact, 94% of respondents in the Cisco 2023 Data Privacy Benchmark Study said customers won’t buy from their

by Chris Radigan & Jamey Cummings | March 30, 2023 Cybersecurity teams are consistently facing three significant challenges today: Accelerated digitization and digital transformation are expanding organizations’ attack surface Cyber-attacks are continuing at a record pace Ongoing shortage in the market for IT and cybersecurity talent Cybercrime is forecast to cause $8 trillion in damage in 2023 and exceed $10 trillion

by Bob Reitinger, William Farkouh, and Jen Valciukas | March 28, 2023 Evolving regulatory environments, shifting customer demands, market disruptors, and pricing challenges are changing the life sciences industry. In this new era, where value creation is no longer only about the products, life sciences companies are placing an increased emphasis on building a strong supply chain via both